CALLOS ANDREW (Chief Commercial Officer) sold 10.7% of their position (8.54K shares) of CYTOKINETICS INC on the open market
Open‑market sale worth $530.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/18/2026ACC: 0001061983-26-000028
Officer· Chief Commercial Officer
Since Mar 2021
-8.54K
Net shares
Net seller
$530.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
8.54K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−5.63K
Price / share
$62.15
Trade value
$349.66K
% of position
7.0%
3/17/2026
80.11K→74.49K
Common Stock
Direct
Shares
−2.92K
Price / share
$62.15
Trade value
$181.23K
% of position
3.9%
3/17/2026
74.49K→71.57K
Total
Net shares
−8.54K
Net value
-$530.89K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2026 | S · Sale | −5.63K | $62.15 | $349.66K | 7.0% | 80.11K | 74.49K |
| Common Stock Direct | 3/17/2026 | S · Sale | −2.92K | $62.15 | $181.23K | 3.9% | 74.49K | 71.57K |
| Total | −8.54K | -$530.89K | ||||||
Derivative Transactions0
No derivative transactions reported